Cardiovascular and renal outcomes with combination exenatide and open-label SGLT2 inhibitor treatment in EXSCEL
DIABETOLOGIA（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined